Julie Lenzer, Chief Innovation Officer at ARMI will present the Opportunities and Challenges of Manufacturing Human Cells, Tissues and Organs. Curing chronic disease and repairing traumatic injuries with engineered cells, cell therapies, tissues, and organs is the next frontier of medicine. This session will provide an overview of the promise of therapies currently in development as well as advances made in manufacturing and commercialization to provide a picture of the health care revolution to come.
Attendees must be registered for the entire series in order to attend.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
